Avid Bioservices, Inc. / Fundamentals

    Income statement

    Net revenue
    €129.08M
    Cost of goods sold
    €119.17M
    Gross profit
    €9.91M
    SG&A expenses
    €27.40M
    R&D expenses
    €0.00
    EBITDA
    -€12.12M
    D&A
    €10.80M
    EBIT
    -€17.49M
    Interest expenses
    €7.22M
    EBT
    -€30.23M
    Tax expenses
    €100.23M
    Net income
    -€130.46M

    Cash flow statement

    Net deferred tax
    €100.24M
    Non-cash items
    €20.27M
    Changes in working capital
    €520.81K
    Operating cash flow
    -€3.10M
    Capex
    -€3.24M
    Other investing cash flow
    -€16.05M
    Net investing cash flow
    -€12.82M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €870.01K
    Debt repayment
    €7.90M
    Other financing cash flow
    €2.12M
    Net financing cash flow
    €10.01M
    Foreign exchange effects
    €0.00
    Net change in cash
    €1.71M
    Cash at end of period
    €28.67M
    Free cash flow
    -€6.34M

    Balance sheet

    Cash and cash equivalents
    €28.67M
    Cash and short-term investments
    €28.67M
    Total receivables
    €25.92M
    Inventory
    €24.09M
    Other current assets
    €4.12M
    Total current assets
    €82.80M
    Property, plant & equipment
    €190.96M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €3.79M
    Total non-current assets
    €194.75M
    Total assets
    €277.55M
    Accounts payable
    €7.94M
    Short-term debt
    €2.48M
    Other current liabilities
    €53.21M
    Total current liabilities
    €63.63M
    Long-term debt
    €175.10M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €374.95K
    Total non-current liabilities
    €175.48M
    Total liabilities
    €239.10M
    Common stock
    €54.91K
    Retained earnings
    -€510.35M
    Other equity
    €0.00
    Total equity
    €38.45M
    Total liabilities and shareholders' equity
    €277.55M

    Company information

    Market capitalization
    €681.42M
    Employees
    371
    Enterprise Value
    €971.01M

    Company ratios

    Gross margin
    7.7% Much better than peer group: -55,732,972,736,820.8%
    EBITDA margin
    -9.4% Much better than peer group: -306,457,236,009,254.8%
    EBIT margin
    -13.5% Much better than peer group: -309,318,140,648,956.5%
    EBT margin
    -23.4% Much better than peer group: -308,951,079,701,780.8%
    Net margin
    -101.1% Much better than peer group: -308,951,079,701,627.5%
    ROE
    -339.3% Much worse than peer group: 86.5%
    ROA
    -47.0% Better than peer group: -63.3%
    Asset turnover
    46.5% Much better than peer group: 19.0%
    FCF margin
    0.1% Much better than peer group: -257,423,878,724,303.2%
    FCF yield
    0.0%
    Efficiency ratio
    109.4%
    Net sales per employee
    €347.93K
    Net income per employee
    -€351.64K

    Notifications